U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06883110) titled 'Angong Niuhuang Pills With Different Bovine Bezoar Formulation Sources in the Treatment of AIS' on March 12.
Brief Summary: This study is a single-center, open-label, controlled clinical trial that prospectively enrolls 100 participants (40 in the Z11020076 group, 40 in the Z20063878 group, and 20 in the blank control group) to collect clinical data, imaging data, and biospecimens over an 84-day follow-up period. The primary objective is to compare the efficacy and safety of Angong Niuhuang Pills from Beijing Tongrentang (Approval No. Z11020076) and Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd. (Approval No. Z20063878) in improving...